Respiratory Distress Syndrome in Premature Infant Clinical Trial
Official title:
Investigating the Effect of Altering the Slope of the Rise in Pressure During Mechanical Ventilation of Preterm Babies
During neonatal mechanical ventilation inflating pressures, tidal volumes, and inflation and expiration times need to be set and adjusted to optimise oxygenation and carbon dioxide removal. The flow of gas into the ventilator circuit has a big effect on ventilation but is usually set to a constant value (~8 L/min) for all babies regardless of size or severity of illness, based on minimal research. High circuit flow may lead to lung damage and low flow to inadequate ventilation. The investigators recently developed a unique system to capture, record, analyse, and display ventilator data at high resolution over long periods. Using this the investigators will investigate, in within patient cross-over studies, how the level of gas flow affects ventilator parameters and ventilation, in two commonly used ventilation modes. The results will determine the lowest circuit flow that ventilates a baby safely and effectively. It will also provide preliminary data for a randomised trial.
- Background of the project
About 1.5% of newborns require mechanical ventilation. Although mechanical ventilation can be
life-saving for neonates with respiratory failure, it may cause lung injury due to excess
airway pressure (barotrauma), delivery of high tidal volumes (volutrauma) and repetitive
closing/re-opening of lung units (atelectotrauma)1. Very preterm neonates are especially
vulnerable to ventilator induced lung injury. Ventilator associated lung injury is one of
several factors contributing to the burden of chronic lung disease of infancy, also called
bronchopulmonary dysplasia (BPD).
Ventilators have several different modes. The most frequently used mode is, time-cycled,
pressure limited, where the doctor sets inspired oxygen level, the peak inflation pressure
(PIP), rate, and inflation time of the ventilator. In this mode the inflations are usually
synchronised with the baby's breathing. This is either Synchronised Intermittent Positive
Pressure Ventilation (SIPPV), where the ventilator synchronises inflations with all the
baby's breaths, or Synchronised Intermittent Mandatory Ventilation (SIMV), where the
ventilator only synchronises with a set number of breaths. These can be delivered with or
without targeting the tidal volume delivered to a set value by adjusting the peak inflating
pressure. This mode is called volume guarantee (VG). A similar mode of ventilation is
flow-cycled or Pressure Support Ventilation (PSV) and can be combined with tidal volume
targeting 2. In this mode the inflation is terminated as soon as the flow rate falls to 15%
of the maximum flow during inflation.
These modes have continuous gas flow through the ventilation circuit. Inflation starts and
pressure rises when the expiratory valve is closed. The rate of circuit flow alters the
ventilation waveforms. With time-cycled ventilation the higher the circuit flow the faster
the pressure rises, the lung is distended and potentially injured, and the earlier the set
PIP is achieved. A high flow, with a relatively long inflation time will result in a
"pressure plateau", that is the PIP is sustained after the flow, into the baby, has stopped
because the lung volume is maximal at the PIP used (Figure 1). In PSV inflation stops when
the flow has decreased to ~15% of the peak inflation flow and so the inflation time is
shorter. Increasing the device flow shortens the inflation time and thereby reduces the mean
airway pressure.
Despite the effects on ventilation patterns and the speed of lung distension and injury,
consideration has rarely been given to the circuit flow. By protocol, it is usually set at
7-10 L/min when the ventilator is turned on and it is not changed.
This is relatively high, and usually produces a "square" pressure waveform with a rapid
distention of the lungs and a sustained pressure plateau. (see A in figure 1) With PSV a high
flow results in a relatively short inflation time (~0.2 sec; it needs to be at least 0.3 sec
for adequate lung aeration). There is no evidence these high flows are best for optimum
ventilation and minimum lung damage. In a preterm lamb model there were no adverse effects on
gas exchange or cardiovascular parameters until the flow was reduced to 3 l/min 3. In animal
studies ventilation with high flow resulted in histologic and molecular changes of lung
injury 4. The effect of lowering the ventilator circuit flow rate has never been investigated
in clinical studies.
The Dräger Babylog VN500 ventilator has an alternative to setting a gas flow: the user can
set the slope time instead, that is time required to reach the set pressure. In Cambridge it
is invariably set to 0.08 sec which results in a flow ~7 L/min. As we use an inflation time
between 0.33 - 0.45 sec, there is a pressure plateau lasting at least 0.25 sec and sustained
inflation with little or no flow.
The investigators are the first to develop a unique system for downloading and analysing data
from the Dräger VN500 neonatal ventilator. Using DataGrabber software obtained from Dräger
Medical, the investigators can retrieve ventilator parameters at 100Hz frequency over long
periods (hours and even days). To analyse and visualise the large datasets the investigators
developed a data analysis workflow using the Python programing language and its add-on
packages (Figure 2). With this tool the investigators can now study details of each inflation
and spontaneous breath. The Investigators have recorded detailed data from 30 babies and
shown it is feasible, accurate, and the investigators have the expertise (Belteki et al,
submitted).
In this application the investigators propose to investigate the effect of different slope
times (and therefore different levels of circuit flow) on ventilation parameters and gas
exchange in preterm infants. The investigators hypothesise that a longer slope time (= lower
circuit flow) will distend the lungs more gently yet maintain ventilation and gas exchange.
- Intervention:
The study is a within patient crossover design comparing short periods of ventilation with
different slope times both in SIPPV-VG and PSV-VG modes with the following interventions:
A ventilator download tool and transcutaneous and expired CO2 monitors is attached to the
ventilator and data download commences while the baby is ventilated with the parameters used
by the clinical team. An arterial blood gas is performed. The ventilated parameters are
changed as shown below. The order of these epochs is randomised. Another arterial blood gas
is performed. Ventilator is changed back to the original parameters (or different as
appropriate by the blood gas). Ventilator data and CO2 recording will be continued for
another 30 minutes.
Interventions
Duration Ventilator More Slope time Inspiratory time[max] 15 min SIPPV-VG 0.08 0.40 15 min
PSV-VG 0.08 [0.60] 15 min PSV-VG 0.16 [0.60] 15 min SIPPV-VG 0.16 0.40 15 min SIPPV-VG 0.24
0.40 15 min PSV-VG 0.24 [0.60] 15 min PSV-VG 0.32 [0.60] 15 min SIPPV-VG 0.32 0.40 15 min
SIPPV-VG 0.40 0.40 115 min PSV-VG 0.40 [0.60]
Total study duration is 220 minutes. A researcher will be present continuously. FiO2 will be
adjusted if needed to maintain saturations between 90-95%. If the FiO2 rises >15% or the
end-tidal CO2 rises >1.5kPa over the pre-study level, that intervention will be abandoned.
Comparison:
At each slope time, the following parameters will be determined and compared with those
recorded at 0.08 sec slope time: (1) peak inflating pressure, (2) inflation duration, (3)
duration of inflation plateau, (4) duration of no gas flow, (5) expired tidal and minute
volumes (mandatory/spontaneous, inspiratory/expiratory, (6) ventilator rate, (7) FiO2, (8)
transcutaneous and/or end-tidal CO2 and, (9) interaction between ventilator inflations and
baby's breaths. Values for SIPPV and PSV will also be compared.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04016246 -
Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation.
|
Phase 3 | |
Enrolling by invitation |
NCT04118400 -
Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature Neonates
|
||
Completed |
NCT01941745 -
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT04019106 -
Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04862377 -
Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
|
Phase 3 | |
Not yet recruiting |
NCT05791331 -
REspiratory MEchanics for Delivering Individualised Exogenous Surfactant
|
N/A | |
Completed |
NCT04086095 -
Feasibility Study - Neofact
|
N/A | |
Not yet recruiting |
NCT05609877 -
The NONA-LISA Trial
|
N/A | |
Recruiting |
NCT04326270 -
Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs
|
N/A | |
Active, not recruiting |
NCT03969992 -
A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact
|
Phase 2 | |
Completed |
NCT03700606 -
Physiological Changes With High-Flow Nasal Cannula
|
N/A | |
Recruiting |
NCT04359134 -
Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.
|
||
Not yet recruiting |
NCT06229821 -
Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants
|
N/A | |
Recruiting |
NCT05446389 -
PAL to Improve Oral Feeding for Infants With Chronic Lung Disease
|
N/A | |
Withdrawn |
NCT04914715 -
nHFOV Versus Invasive Conventional Ventilation for Preterm Neonates With Respiratory Distress Syndrome
|
N/A | |
Recruiting |
NCT03825835 -
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
|
N/A | |
Recruiting |
NCT03562182 -
Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA
|
||
Completed |
NCT05031650 -
Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room
|
N/A | |
Completed |
NCT01473264 -
Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)
|
Phase 1/Phase 2 | |
Completed |
NCT03548324 -
Enteral Nutrition Tolerance And REspiratory Support (ENTARES)
|
N/A |